Thursday, 14th July 2022
14:00 London BST | 09:00 New York EDT
The global healthcare sector is no longer dominated by Covid-19, mainly due to the widespread roll-out of vaccines. Provision of medical services is nevertheless still impacted by the consequences of the pandemic, such as changes to government health budgets, reassessment of universal healthcare goals and hype surrounding digital health.
The industry is also increasingly affected by wider macroeconomic and geopolitical factors, such as high inflation, pressure on supply chains, US-China tensions, reduced globalisation, and the Russia-Ukraine war.
This webinar will cover the following topics:
Head of Pharmaceuticals, Healthcare & Medical Devices
Based in London, Jamie leads a global team of analysts in identifying market entry and expansion opportunities, assessing operational risks and analyzing corporate growth strategies. Prior to joining BMI in 2006, Jamie wrote for Thomson Scientific and tracked investigational drugs through clinical trials at PharmaProjects. 杰米从国王学院毕业, London with a degree in Pharmacology with Management and received an MBA from the Open University in 2019.
THIS COMMENTARY IS PUBLISHED BY FITCH SOLUTIONS COUNTRY RISK & INDUSTRY RESEARCH and is NOT a comment on Fitch Ratings' Credit Ratings. Any comments or data are solely derived from Fitch Solutions Country Risk & Industry Research and independent sources. Fitch Ratings analysts do not share data or information with Fitch Solutions Country Risk & Industry Research.
Get to know the business behind the products. Meet some of our key people and explore our credentials.
Our latest articles and views on
industries, regions, and topics.
